Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The optimal treatment of hyperglycemia in general surgical patients with type 2 diabetes mellitus is not known. RESEARCH DESIGN AND METHODS: This randomized multicenter trial compared the safety and efficacy of a basal-bolus insulin regimen with glargine once daily and glulisine before meals (n = 104) to sliding scale regular insulin (SSI) four times daily (n = 107) in patients with type 2 diabetes mellitus undergoing general surgery. Outcomes included differences in daily blood glucose (BG) and a composite of postoperative complications including wound infection, pneumonia, bacteremia, and respiratory and acute renal failure. RESULTS: The mean daily glucose concentration after the 1st day of basal-bolus insulin and SSI was 145 ± 32 mg/dL and 172 ± 47 mg/dL, respectively (P < 0.01). Glucose readings <140 mg/dL were recorded in 55% of patients in basal-bolus and 31% in the SSI group (P < 0.001). There were reductions with basal-bolus as compared with SSI in the composite outcome [24.3 and 8.6%; odds ratio 3.39 (95% CI 1.50–7.65); P = 0.003]. Glucose <70 mg/dL was reported in 23.1% of patients in the basal-bolus group and 4.7% in the SSI group (P < 0.001), but there were no significant differences in the frequency of BG <40 mg/dL between groups (P = 0.057). CONCLUSIONS: Basal-bolus treatment with glargine once daily plus glulisine before meals improved glycemic control and reduced hospital complications compared with SSI in general surgery patients. Our study indicates that a basal-bolus insulin regimen is preferred over SSI in the hospital management of general surgery patients with type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As discussed in Q12. How can glycemic targets be achieved in persons with T2D? as well as in the AACE Comprehensive Type 2 Diabetes Management Algorithm,73 some newer therapies carry a lower risk of hypoglycemia, which may enable more persons to safely achieve individualized target A1C levels.69,88–90”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A randomized controlled trial has shown that basal plus bolus insulin plan improved glycemic outcomes and reduced hospital complications compared with a correction or supplemental insulin without basal insulin (formerly known as sliding scale) for people with type 2 diabetes admitted for general surgery (74).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“In individuals undergoing noncardiac general surgery, basal insulin plus premeal short-or rapid-acting insulin (basal-bolus) coverage has been associated with improved glycemic outcomes and lower rates of perioperative complications compared with the reactive, correction-only short-or rapid-acting insulin coverage alone with no basal insulin dosing (74,145).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [74]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Intensive glucose control (A1C levels <7% in T2D and <7.5% in T1D) in several clinical trials was found to reduce the risk of incident albuminuria (A2) and DKD onset.70,78,90,406–410”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [90]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 1×
“…setting, observational and prospective clinical trials have shown that hyper-glycemia is associated with increased rates of hospital complications and mortality (8,10,11) and that improved glycemic control reduces multiorgan failure, systemic infections, and short-and long-term mortality (7,8).”
BackgroundHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationManagement of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
Furnary, A. P., Gao, G., Grunkemeier, G. L., Wu, Y., Zerr, K. J., Bookin, S. O., Floten, H. S., & Starr, A. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2003.181 · Cited by 1,130
Lazar, H. L., Chipkin, S. R., Fitzgerald, C. A., Bao, Y., Cabral, H., & Apstein, C. S. (2004) · Circulation · doi:10.1161/01.cir.0000121747.71054.79 · Cited by 717
Early Postoperative Glucose Control Predicts Nosocomial Infection Rate in Diabetic Patients
Pomposelli, J. J., Baxter, J. K., Babineau, T. J., Pomfret, E. A., Driscoll, D. F., Forse, R. A., & Bistrian, B. R. (1998) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719802200277 · Cited by 700 · cited 2×
“7 times increased rate of infection (13).”
BackgroundUmpierrez, G. E., Smiley, D., Zisman, A., Prieto, L. M., Palacio, A., Ceron, M., Puig, A., & Mejia, R. (2007) · Diabetes Care · doi:10.2337/dc07-0295 · Cited by 671
Self-citationHyperglycemic Crises in Adult Patients With Diabetes
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., & Kreisberg, R. A. (2006) · Diabetes Care · doi:10.2337/dc06-9916 · Cited by 512
Self-citationManagement of Hyperglycemia in the Hospital Setting
Inzucchi, S. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp060094 · Cited by 391
Cited by
Items 701–733 of 733
Perioperative control of blood glucose
Kuşkonmaz, Ş. M., & Arslan, M. (2015) · Medical Science and Discovery · doi:10.36472/msd.v2i3.85
Velasco, M. Á. P., Osuna‐Sánchez, J., Millán‐Gómez, M., Ricci, M., Sampalo, A. L., Bernal-López, M. R., Gómez‐Huelgas, R., & Perez-Belmonte, L. M. (2025) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2024.10.023 · Cited by 2
Hypoglycemia in the Patient with Diabetes
Hudson, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-86099-7_23
Abdallah, N., Giuliano, C. A., Rukat, C. E., & Barnes, B. J. (2025) · Hospital Pharmacy · doi:10.1177/00185787251352168
“11,12 Furthermore, patients in the RABBIT 2 Surgery trial also had fewer postoperative complications, including wound infections and pneumonia, without an increased risk of severe hypoglycemia.”
Mannion, J. D., Rather, A., Fisher, A., McEvilly, M., Gardner, K., & Siegelman, G. (2025) · BMC Surgery · doi:10.1186/s12893-025-03040-2
“The basal/bolus insulin approach was used postoperatively to treat patients with diabetes [13], whether or not they were treated preoperatively with insulin or oral agents.”
Exploring the heterogeneity in recurrent episode lengths based on quantile regression
Liu, Y., Umpierrez, G. E., & Peng, L. (2025) · Biometrics · doi:10.1093/biomtc/ujaf122
Self-citationRigotti, A. R. (2025) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.22.2025.tde-08102025-130041
Huppert, C. A., Moore, E. A., Kania, D. S., Cann, K., & Knefelkamp, C. A. (2025) · Federal Practitioner · doi:10.12788/fp.0645
Jian, J., & Sun, X. (2025) · The Journal of Arthroplasty · doi:10.1016/j.arth.2025.08.044
Schechter, M. C., Rhodes, E., Shao, H., Ahmed, S. N., Colquitt, K., Chaudhry, N. A., Dunlop, A. L., FLORES, J., García-Toca, M., Javia, V. N., et al. (2025) · medRxiv · doi:10.1101/2025.11.25.25340976
“Glycemic control: Justification: Our group and others have shown that optimized glycemic control promotes wound healing, including for DFU 38–40 .”
Self-citationvon Dossow, V., Fliegenschmidt, J., & Bergmann, A. (2025) · Die Diabetologie · doi:10.1007/s11428-025-01401-2
“Auch in einer multizentrischen, prospek-tiven Beobachtungsstudie ( n = 224) war bei Patienten mit einer Kraniotomie eine schwere intraoperative Hyperglykämie (>10mmol/l)miteinemhöherenRisikofür postoperative Infektionen assoziiert (OR [95%-KI]: 4,2 [1,5; 11,5]; p = 0,006, [25]).”
Management of Diabetes and Hyperglycemia in the Hospital Setting
DeMauro-Jablonski, S., & Inzucchi, S. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_47
Vassighi, R. (2025) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/khej-7v97
Ribeiro, M. O. (2024) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/eg4d-2d04
Dr. Shakeel Ahmad, D. S. K. (2018) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.1407496
Ramos, A. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Chen, L. Q., Taleb, N., NADON, N., Godbout, A., Lysy, Z., SGARIGLIA, B., Boivin, M., Boucher, A., & Boutin, J. (2026) · Diabetes Obesity and Cardiometabolic CARE · doi:10.2337/doc25-0060
Perioperative Glycemic Management in the Adult Patient
Duggan, E. W., & Mazer, C. D. (2026) · Medical Clinics of North America · doi:10.1016/j.mcna.2025.11.011
Chawla, M. S., Viswanathan, V., Agarwal, S., Maheshwari, A., Sahay, R. K., Jethwani, P., Ghosh, S. K., Gupta, S., Kanodia, N., Unnikrishnan, A. G., et al. (2026) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-026-01634-x · Cited by 1
“• Starting dose : 0.3–0.5 U/kg/day for most patients [3, 37, 52]. o Elderly or renal impairment: ≤ 0.3 U/kg/day [3]. o Avoid starting > 0.6–0.8 U/kg/day to reduce hypo-glycemia risk.”
InfluentialCandia, D. S., Gil, M. X. M., Nieto, A. J., & Sánchez, L. P. C. (2023) · Repositorio Institucional Universidad El Bosque · Cited by 1
Low‐value glucose monitoring in noncritically ill hospitalized patients
Latifi, N., Mathioudakis, N. N., Abusamaan, M. S., Tschudy, M. M., Ma, J., Olson, S., Jouaneh, T. M. M., Yang, A., & Brotman, D. J. (2026) · Journal of Hospital Medicine · doi:10.1002/jhm.70319
Amatya, A., Pudasaini, A., Bajrachaya, S. M., Shrestha, B. K., Bhandari, S., Khadka, A., Pandey, P., & Poudel, S. (2026) · Nepalese Heart Journal · doi:10.3126/nhj.v23i1.95123
Alkuwaiti, M., Pedo, V. G., & Agha, A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1887754
“The RABBIT 2 randomized trial demonstrated that basal-bolus regimens achieve substantially better glycemic control than sliding-scale insulin alone in hospitalized patients with diabetes without increasing hypoglycemia (30).”
Osawa, H., Obi, K., Rahman, M., & Noto, H. (2026) · Internal Medicine · doi:10.2169/internalmedicine.7564-26
Shimokawa, S., Yamamoto, K., Hisai, T., Fukushima, M., Fujiwara, K., Koyanagi, Y., Notomi, S., Ishikawa, K., Tsukamoto, S., Hirata, A., et al. (2026) · Ophthalmology Science · doi:10.1016/j.xops.2026.101381
Zheng, S., Anwar, A., Zhong, W., & Yan, X. (2026) · Frontiers in Surgery · doi:10.3389/fsurg.2026.1907176
Stress-Induced Hyperglycemia in General Surgery
Zaino, J., Diaz-Sarmiento, V. S., Idrees, T., & Umpierrez, G. E. (2026) · Clinics in Perioperative Nursing Care · doi:10.1016/j.pernc.2026.05.005
Self-citation堀切, 陽., Ogiso, K., Kusumoto, K., Kubo, T., Kurano, M., Kawade, S., Arimura, A., Deguchi, T., Shinnakasu, A., Horinouchi, S., et al. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70435
“Intensive glycemic control, particularly with basal – bolus insulin regimens, reduces SSI and other complications compared with sliding-scale protocols 23 .”
Ali, A., Naeem, U., & Babur, M. (2026) · Journal of Health Wellness and Community Research · doi:10.61919/4pe13420
Bahru, Y. D., Berha, A. B., Ahmed, A., & Chelkeba, L. (2026) · Research Square · doi:10.21203/rs.3.rs-10815003/v1
Gaytán-Santillán, A., Soto-Mota, A., Ramos, D. C., Mehta, R., & Gulías-Herrero, A. (2026) · Diabetes Therapy · doi:10.1007/s13300-026-01937-6
Abdominal Aortic Aneurysms in Patients with Diabetes
Johnston, W. F., & Upchurch, G. R. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-158-5_15
Metadata
- Authors
- Umpierrez, G. E., Smiley, D., Jacobs, S., Peng, L., Temponi, A., Mulligan, P., Umpierrez, D., Newton, C., Olson, D., & Rizzo, M.
- Affiliations
- Grady Memorial Hospital (US)
- Emory University (US)
- Department of Medicine, Emory University, Atlanta, Georgia
- Corresponding author
- Umpierrez, Guillermo E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-01-20
- Volume
- 34
- Issue
- 2
- Pages
- 256-261
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3024330
- OpenAlex
- W2106327047
- Cited by
- 720
- References
- 24
- Citations by year
- 2026: 19 · 2025: 36 · 2024: 37 · 2023: 47 · 2022: 53 · 2021: 37 · 2020: 44 · 2019: 52 · 2018: 55 · 2017: 54 · 2016: 48 · 2015: 51 · 2014: 61 · 2013: 53 · 2012: 44
- FWCI
- 48.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR000454)
- National Institute of Diabetes and Digestive and Kidney Diseases (R03DK073190)
- National Center for Research Resources (M01-RR00039, K12RR017643, M01RR000039)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, multiple daily insulin injections, glargine, glulisine, sliding scale insulin, general surgery, perioperative hyperglycemia, glycemic control, postoperative complications, wound infection, respiratory failure, acute kidney injury, bacteremia
- MeSH terms
- Insulin Glargine, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Inpatients, Insulin, Male, Middle Aged, Postoperative Complications, Prospective Studies, General Surgery, Perioperative Care, Insulin, Long-Acting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.